Evidence map›Paper›PMID 40250881›Full record

ArticleRMD open2025

Myocardial infarction in ANCA-associated vasculitis: a population-based cohort study.

Ylva Borgas, Moman Aladdin Mohammad, Karl Gisslander, Jens Rathmann, David Erlinge, David Jayne, Aladdin J Mohammad

Abstract read
In one paragraph

Article in RMD open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Proceedings of the 2Mediterranean journal of rheumatology · 2026
    Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ylva BorgasDepartment of Rheumatology, Skåne University Hospital, Malmo, Sweden ylvaborgas@gmail.com.ORCID 0000-0002-3684-1093
Moman Aladdin MohammadDepartment of Clinical Sciences, Skåne University Hospital, Lund University, Lund, Sweden.
Karl GisslanderDepartment of Clinical Sciences, Skåne University Hospital, Lund University, Lund, Sweden.ORCID 0000-0003-1915-2656
Jens RathmannDepartment of Clinical Sciences, Skåne University Hospital, Lund University, Lund, Sweden.ORCID 0000-0001-5085-7684
David ErlingeDepartment of Clinical Sciences, Skåne University Hospital, Lund University, Lund, Sweden.
David JayneDepartment of Medicine, University of Cambridge, Cambridge, UK.ORCID 0000-0002-1712-0637
Aladdin J MohammadDepartment of Clinical Sciences, Skåne University Hospital, Lund University, Lund, Sweden.ORCID 0000-0002-7169-6936

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo determine the incidence rate (IR) and predictors of myocardial infarction (MI) in patients with antineutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis (AAV) as well as to estimate the IR ratio (IRR) of MI in AAV versus the background population.

methods325 patients diagnosed with AAV 1997-2016 in Skåne, Sweden were included. Data were collected from the time of AAV diagnosis, and each patient was grouped with 10 age-matched and sex-matched reference subjects from the background population. MI after AAV diagnosis was identified using Swedish Web-System for Enhancement and Development of Evidence-based Care in Heart Disease Evaluated According to Recommended Therapies and the Skåne Healthcare Register, and IR of first MI calculated. The IRR was computed by dividing the IR for 282 AAV patients by the corresponding rate in the 2763 reference subjects. Predictors of MI were analysed using Cox regression.

results37 patients (11%) with AAV suffered an initial MI, yielding an IR of 1.6/100 person-years of follow-up (95% CI 1.2 to 2.2). The highest rate was recorded in the 3 months following AAV diagnosis, at 11.8/100 person-years (95% CI 6.2 to 22.7). The IRR of MI in AAV/reference was 1.9 (95% CI 1.3 to 2.8), highest in patients with myeloperoxidase-ANCA+disease (IRR 2.5, 95% CI 1.5 to 4.3) and those with high disease activity at diagnosis (2.1, 95% CI 1.3 to 3.3). Age at AAV diagnosis independently predicted MI.

conclusionsThe MI IR is greater in individuals diagnosed with AAV compared with background population, especially those with more severe disease, and highest in the 3 months following diagnosis. Age at diagnosis is the single independent predictor of MI in AAV in this study.

Indexed as

Anti-Neutrophil Cytoplasmic Antibody-Associated VasculitisMyocardial InfarctionAdultAgedCohort StudiesFemaleHumansIncidenceMaleMiddle AgedRegistriesRisk FactorsSwedenGranulomatosis with polyangiitisMyocardial infarctionVasculitis

Identifiers

PMID40250881
PMCPMC12007036

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.